Allchem Lifescience IPO GMP, Grey Market Premium Today

Check out Allchem Lifescience IPO GMP aka IPO Grey Market Premium, Kostak rates, and Subject to Sauda rates as of today. Allchem Lifescience IPO GMP is not started in grey market, lets wait for the IPO announcement. Stay tuned for the latest IPO GMP numbers of Allchem Lifescience IPO.
Allchem Lifescience IPO

Allchem Lifescience IPO is to open on 2026. It is a Mainboard IPOĀ that will raise ₹[.] crores. The Allchem Lifescience IPOĀ price band is fixed at ₹[.] to ₹[.] with a market lot of [.] Shares.

Allchem Lifescience IPO GMP Live Rates day by day with Kostak rates.

DateIPO GMPGMP TrendGain
4 April₹--%

Allchem Lifescience IPO Details

IPO Open Date2026
IPO Close Date2026
Face Value₹10 Per Equity Share
IPO Price Band₹[.] to ₹[.] Per Share
Issue SizeApprox ₹[.] Crores
Fresh IssueApprox ₹190 Crores
Offer for Sale:Approx 7,155,000 Equity Shares
Issue TypeBook Building Issue
IPO ListingBSE, NSE
DRHP Draft ProspectusPDF
RHP Draft ProspectusPDF

Allchem Lifescience IPO Dates

IPO Open Date:2026
IPO Close Date:2026
Basis of Allotment:2026
Refunds:2026
Credit to Demat Account:2026
IPO Listing Date:2026
IPO Bidding Cut-off Time:2026 – 5 PM

Business Overview

To be updated soon


Allchem Lifescience IPO GMP aka Grey Market Premium FAQs:


What is Allchem Lifescience IPO GMP Today?

Allchem Lifescience IPO GMP is ₹- as of today.

What is Allchem Lifescience IPO Expected Returns?

Allchem Lifescience IPO Expected Returns is -%.

Disclaimer:

  • IPO Grey Market Premium (Allchem Lifescience IPO GMP) mention is valid for the specific date as mentioned in the header.
  • We are not buying and selling IPO forms on IPO Grey Market.
  • Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
  • Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.

Table of Contents

Founder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *